Opportunity Journey
Welcome to a new student seminar in the Opportunity Journey!
This time we will be visited by Simon Dankel. He is a professor at the Clinical Institute 2 and an expert in nutrition and lifestyle diseases. At the seminar, Dankel will tell more about his exciting research.
As usual, there will be mingling and pizza after the lecture.
Dear all,
The new KG Jebsen Centre for myeloid blood cancer (c-myc) at K2, UiB presents a seminar at Solstrand Hotel 12th of may focusing on single-cell technologies, i.e CyTOF.
There will be presentations by several international experts in the field such as Jonathan Irish, Erwin Schoof, and Rachel Thijssen.
You may see the programme for the single cell satelite seminar here: https://cmyc.w.uib.no/2025/02/05/c-myc-single-cell-satellite-seminar-may-12th-2025/
The meeting is heavily subsidized with a registration fee of 1500 NOK, including food and accommodation.
Please register before the 1st of april here:
https://skjemaker.app.uib.no/view.php?id=18505265
The seminar is followed by the yearly CCBIO Symposium where Sir David Lane and Eva Hellström-Lindberg among others will present their work. https://www.uib.no/en/ccbio/160316/ccbios-13th-annual-symposium-
Want to become an outstanding communicator? Are you a Ph.D. student? Then we can help you!
Researcher Grand Prix is the Norwegian Championship in research communication and a great opportunity to improve your communication skills. As a participant, you get a fantastic chance to learn more about how to reach a large audience with your message.
We provide individual coaching where you learn more about storytelling, presentation techniques, voice usage, op-ed writing, media handling, and creative thinking.
Researcher Grand Prix will be held on September 17th in Bergen. The national final will be in Oslo on September 25th.
Application deadline: April 30th!
https://www.forskningsdagenebergen.com/bergen/forsker-grand-prix-2025/
The rector election is approaching! On Monday March 17, 10:00 to 11:00, both rector teams running for election will be present in the main auditorium, Haukeland (next to the cafeteria on floor 3). There will be short presentations and an open floor for questions from the audience.
Candidate from Clinical Institute 2
Main Supervisor: PhD Elisabeth Leirgul
Co-supervisors: Professor Nina Øyen and PhD Ferenc Macsali
Location: Auditorium, Glasblokkene 8, Haukelandsbakken 1
Assigned Topic: “Maternal cardiovascular disorders during pregnancy: Impact on fetal-neonatal and long-term child health”
Location: Auditorium, Glasblokkene 8, Haukelandsbakken 1
Thesis Title: “Childbearing in women with congenital heart disease. A nationwide cohort study from Norway 1994-2014”
The disputation will be led by Professor Jone Trovik.
Hi everyone!
Spring’s most beautiful adventure is approaching rapidly, and we therefore remind you to sign up to help! 😄
OSKE12 takes place on June 5th, and OSKE6 is on June 12th.
Link to sign-up form
We need all good hands on deck to make this happen!
This is a fantastic opportunity to meet colleagues across institutes and faculties. We also hope that you have the opportunity to join!
If there are any questions or anything else, just contact me.
This is going to be great! 😎
This year’s internal control focuses mainly on the disposal of chemicals. It is an important HSE measure to get an overview of this and remove those we no longer use.
Link to the form: https://skjemaker.app.uib.no/view.php?id=18400083
Deadline for submission is 02.05.
On March 24th, all employees with a 40% position or more will receive a questionnaire by email. There have been significant changes in the survey since last time, some of the changes are:
The survey gives you, as an employee, an opportunity to say something about how you are doing at work and how to influence your own work environment.
All employees at UiB are expected to contribute to a good working environment in their units, this time by responding to the work environment survey and participating in the follow-up of it.
Video for international employees: Joint work environment survey at UiB 2024-2025
The development of medtech products is characterized by a long time to market and requires significant equity financing to succeed. When launching a product in the medtech sector, there is an enormous jungle of words to navigate. Especially, the regulatory requirements are many and constitute a vast and unknown territory for entrepreneurs and investors. At Inventas, we have nearly 30 years of experience in product development and have developed a methodology (or playbook, if you will) for how we can adapt product, business, and regulatory roadmaps with a tailored go-to-market strategy. In the presentation, we will emphasize the success factors and pitfalls you will encounter in the roadmap and how we can adjust them both in terms of development stages and timing. This will enable you to develop a product (or a startup on a development path) in the fastest and most cost-effective way, without taking illegal shortcuts.
https://www.linkedin.com/events/vaffelpitchp-eitrimedkaygasting7304149937754107905
Monday, March 17, 2025, 11:30 AM – 3:00 PM
A record number of people are being diagnosed with diabetes. The Bergen-based company Lifecare is now contributing to revolutionizing patient safety and comfort through groundbreaking methods for monitoring glucose levels.
To shed light on developments in continuous glucose monitoring (CGM), Eitri, the Bergen Chamber of Commerce, and Lifecare have gathered renowned international experts for this exciting symposium.
The report “Health Industry Export”, prepared by Menon Economics with input from several stakeholders, including LO, NHO, Abelia, IKT-Norge, the Norwegian Association of Pharmaceutical Manufacturers (LMI), the Directorate of Health, the Research Council of Norway, and the Oslo Cancer Cluster, was published recently.
While there are signs of increased revenue, employment, and exports within this sector, there is a negative trend in R&D investments, industrial production, and general investments. The profitability of the health industry has weakened in recent years. The pharmaceutical industry accounts for 74 percent of the health industry’s total exports, but a few large pharmaceutical companies represent a major share.
The pharmaceutical industry is an example of an R&D-intensive sector, and the report reveals challenges such as declining use of NRC SkatteFUNN and fewer patents. The number of SkatteFUNN projects, which are intended to stimulate increased R&D in the business sector, has fallen by 17% from 2021 to 2023.
Meanwhile, researchers in Norwegian academic institutions are beginning to feel the economic tightening affecting the sector. The 2024 report from the Research Association’s survey detailing employees’ experience clearly shows researchers’ concerns that the lack of investment in the field will result in weakened research quality and reduced innovation potential. They fear less time and energy for actual research activities, applying for external funding, and not least for the creative process of coming up with new ideas. Innovation is a surplus phenomenon that requires energy, time, and forums that facilitate interdisciplinary meetings. Outcomes may take time to materialize, and will not be visible in the next annual report.
Against this background, the findings in the Menon report may not be so surprising. The gap between ambitions and conditions becomes apparent. Perhaps the new situation will drive innovation according to the saying “necessity is the mother of invention”. Innovative approaches can be part of the solutions to present challenges in and of themselves. It remains to be seen how the sector will adapt to the new realities, but it is clear that both challenges and opportunities are ahead.
Congratulations to Eva Gerdts for being awarded the Meltzer Prize for outstanding communication yesterday at the Meltzer Dinner.
Vinnere av årets Meltzerpriser | Aktuelt | UiB
